CHA sent a comment letter to the FDA on draft guidance that recommends how and when manufacturers provide additional information in drug shortage notifications to the agency. Our letter urges the FDA to address the specific challenges facing the pediatric drug supply chain through transparency requirements, developing proactive shortage mitigation plans, and ensuring an accounting of pediatric drugs on the FDA drug shortages list.
CHA Submits Comments on FDA Drug Shortage Guidance
Children’s Hospital Association sends a comment letter to the FDA on draft drug shortage guidance to highlight the need for an efficient pediatric supply chain.
Related Content
A New Blueprint for a Resilient Pediatric Supply Chain
CHA Leads Comments with Child Health Groups in Response to Proposed Rule
Protecting Children’s Access to Care: H.R. 1 Mitigation-Related Resources
A New Blueprint for a Resilient Pediatric Supply Chain
An unprecedented pilot public-private collaboration shows promise in mitigating drug shortages.
March 24, 2026
CHA Leads Comments with Child Health Groups in Response to Proposed Rule
Our joint comment letter highlights the implications for children’s health and children’s hospitals.
March 20, 2026
Protecting Children’s Access to Care: H.R. 1 Mitigation-Related Resources
H.R. 1 makes significant changes to the Medicaid program and includes policies that will limit children’s access to care.
March 20, 2026
